Lucid Diagnostics Inc. (LUCD) stock forecast and price target
Price $0.45 · data as of November 13, 2026
12-month price target
Average target$4.00
Upside / downside+790.7%
Analysts5
ConsensusStrong buy
Low $2.00Average $4.00High $9.50
Gold marker: average target · white marker: today’s price ($0.45)
Analyst ratings
Strong buy 1Buy 3Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.24 | +43.4% | $6M |
| Next fiscal year ends December 31, 2027 | $-0.17 | +31.2% | $18M |
| Next quarter ends December 31, 2026 | $-0.06 | +45.0% | $2M |
| Quarter after ends March 31, 2027 | $-0.04 | +42.9% | $3M |
Consensus of the analysts covering Lucid Diagnostics, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Frequently asked questions
What is the Lucid Diagnostics stock price target?
The average 12-month target from 5 analysts is $4.00, 790.7% above the current price of $0.45 Targets range from $2.00 to $9.50.
Is Lucid Diagnostics a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Lucid Diagnostics expected to earn?
Analysts expect EPS of $-0.24 for the fiscal year ending December 31, 2026 and $-0.17 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.